David le, DPM
Podiatrist · Oklahoma City, OKNPI 1962566307
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.6% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Smith+Nephew at 25.3% of the total. Reporting peaked in 2019 at $480 and has fallen 93.7% since, to $30 in 2025. That places this record below the midpoint for podiatrist clinicians in OK, where the typical reported total is $1,579.
Across 49 payments — averaging $30.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$374
- Organogenesis Inc.$270
- Trice Medical, Inc.$175
- Tenex Health Inc.$154
- Medtronic$121
- KCI USA, Inc.$107
- plus $279 from 8 others
What the payments were for
- Speaking & faculty fees$1097%
- Food & beverage$1,37093%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 23 | $374 |
| Organogenesis Inc. | 4 | $270 |
| Trice Medical, Inc. | 1 | $175 |
| Tenex Health Inc. | 1 | $154 |
| Medtronic | 2 | $121 |
| KCI USA, Inc. | 2 | $107 |
| Stryker(2 entities) | 3 | $87 |
| Zyla Life Sciences, Inc. | 5 | $62 |
| Melinta Therapeutics, LLC | 3 | $41 |
| Nevro Corp. | 1 | $21 |
| Acera Surgical, Inc. | 1 | $20 |
| Abbott | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Osiris Therapeutics Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Affinity$119
- Apligraf$109
- Dermagraft$109
- Puraply/Affinity/NuTech$109
- INTELLIS ADAPTIVESTIM$107
How this compares
$1,479 in reported general payments places this provider in the 45th percentile of 54 podiatrist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $200 |
| SsdSilver Sulfadiazine | 15 | $84 |
| Indomethacin | 12 | $69 |
| Silver Sulfadiazine | 12 | $50 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Oklahoma City
- David CavallaroOklahoma City$22K
- Patricia BoehleOklahoma City$10K
- Andrea SeatOklahoma City$5K
- Angela SchuffOklahoma City$4K
- James FlynnOklahoma City$4K
- Terry NayfaOklahoma City$3K
- Kenneth GoldaOklahoma City$2K
- David WadeOklahoma City$2K
- Wolfgang KienzleOklahoma City$2K
- Benjamin HarkessOklahoma City$955
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.